302 genotypes with 395 annotations displayed
of selected term and subterms
|
Searched Term: increased liver tumor incidence
|
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
|
increased hepatocellular carcinoma incidence
|
J:21232
|
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
|
increased hepatocellular carcinoma incidence
|
J:217802
|
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor)
|
increased hepatocellular carcinoma incidence
|
J:217802
|
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N)
|
increased hepatocellular carcinoma incidence
|
J:335836
|
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:174942
|
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:35794
|
increased hepatoma incidence
|
J:48180
|
Acox2em1Jynz/Acox2em1Jynz
(involves: C57BL/6N)
|
increased liver tumor incidence
|
J:323193
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
increased hepatoma incidence
|
J:44690
|
increased liver adenoma incidence
|
J:44690
|
Albtm1(cre/ERT2)Mtz/Alb+ Krastm4Tyj/Kras+ Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae)
|
increased hepatocellular carcinoma incidence
|
J:254370
|
Altretm1.1Hbgl/Altretm1.1Hbgl Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased liver tumor incidence
|
J:342907
|
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm)
|
increased liver tumor incidence
|
J:221247
|
Anxa7tm1Pll/Anxa7+
(B6.Cg-Anxa7tm1Pll)
|
increased hepatocellular carcinoma incidence
|
J:93685
|
ApcMin/Apctm1Tno Ctnnb1tm4.1Wbm/Ctnnb1+
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:156864
|
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:20443
|
Apctm1Tno/Apc+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:156864
|
Apctm1Tno/Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:156864
|
Apctm2.1Cip/Apctm2.1Cip
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased hepatocellular carcinoma incidence
|
J:94721
|
Apctm2Rfo/Apc+
(B6.129P2-Apctm2Rfo)
|
increased liver tumor incidence
|
J:151494
|
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1)
|
increased liver tumor incidence
|
J:151494
|
Apctm2Rfo/Apc+
(129P2/OlaHsd-Apctm2Rfo)
|
increased liver tumor incidence
|
J:151494
|
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd)
|
increased liver adenocarcinoma incidence
|
J:176672
|
Atmtm1Awb/Atmtm1Awb
(A.129S6-Atmtm1Awb)
|
increased hepatocellular carcinoma incidence
|
J:208539
|
Atp11cambr/Y
(C57BL/6-Atp11cambr)
|
increased hepatocellular carcinoma incidence
|
J:171924
|
AurkaGt(XQ0149)Wtsi/Aurka+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatoma incidence
|
J:143099
|
Aurkbtm1.2Mama/Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL)
|
increased liver adenocarcinoma incidence
|
J:173575
|
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:86953
|
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:86982
|
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:105076
|
increased liver adenoma incidence
|
J:105076
|
Bhlha15tm2(Kras)Skz/Bhlha15+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:105076
|
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:177569
|
increased liver adenoma incidence
|
J:177569
|
increased liver tumor incidence
|
J:177569
|
Brca1tm2Cxd/Brca1tm2Cxd Pkmtm1.1Mgvh/Pkmtm1.1Mgvh Trp53tm1Brd/Trp53+ Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
|
increased liver tumor incidence
|
J:205213
|
Brca1tm3Cxd/Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N)
|
increased hepatoma incidence
|
J:94114
|
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
|
increased liver tumor incidence
|
J:155810
|
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased liver tumor incidence
|
J:143035
|
Bub1tm2Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:135093
|
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:201641
|
Catb/Catb
(C3.Cg-Catb/Anl)
|
increased hepatoma incidence
|
J:154291
|
Cbx7tm1Afus/Cbx7+
(involves: C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:184383
|
increased liver adenoma incidence
|
J:184383
|
Cbx7tm1Afus/Cbx7tm1Afus
(involves: C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:184383
|
increased liver adenoma incidence
|
J:184383
|
increased liver tumor incidence
|
J:184383
|
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6N)
|
increased hepatocellular carcinoma incidence
|
J:216704
|
Ccndbp1tm1Riet/Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:121623
|
increased liver adenoma incidence
|
J:121623
|
Ccng1tm1Sst/Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6)
|
increased hepatoma incidence
|
J:106007
|
Cdc20tm1.1Pzg/Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased hepatoma incidence
|
J:150421
|
Cdkn1atm1(HBsAg)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
|
increased hepatocellular carcinoma incidence
|
J:88078
|
Cdkn1atm1(HBsAg)Xya/Cdkn1atm1(HBsAg)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
|
increased hepatocellular carcinoma incidence
|
J:88078
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Fahtm1Mgo/Fahtm1Mgo
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:138701
|
Cdkn1atm2(HBx)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
|
increased hepatocellular carcinoma incidence
|
J:88078
|
Cdkn1atm2(HBx)Xya/Cdkn1atm2(HBx)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
|
increased hepatocellular carcinoma incidence
|
J:88078
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N)
|
increased liver tumor incidence
|
J:131179
|
Cers2Gt(S16-4B1)Sor/Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:156841
|
increased liver tumor incidence
|
J:156841
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+ Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
increased hepatocellular carcinoma incidence
|
J:217463
|
increased liver adenoma incidence
|
J:217463
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+ Tg(Cebpb-tTA)#Bjd/0 Trp53tm1Gev/Trp53+
(B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
increased hepatocellular carcinoma incidence
|
J:217463
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
increased hepatocellular carcinoma incidence
|
J:217463
|
Ctnnb1tm1Mmt/Ctnnb1+ Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased hepatoblastoma incidence
|
J:112659
|
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased hepatoblastoma incidence
|
J:112659
|
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased liver tumor incidence
|
J:170976
|
Ddit3tm1.1Irt/Ddit3tm1.1Irt Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Mup3-Plau)350-2Eps/?
(involves: C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:233146
|
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv)
|
increased hepatoma incidence
|
J:198831
|
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:145228
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:163795
|
increased liver adenoma incidence
|
J:163795
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:138701
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
|
increased hepatocellular carcinoma incidence
|
J:27735
|
increased hepatoma incidence
|
J:27735
|
increased liver adenoma incidence
|
J:27735
|
increased liver tumor incidence
|
J:27735
|
Fancmtm1.1Htr/Fancmtm1.1Htr
(involves: C57BL/6 * FVB)
|
increased hepatoma incidence
|
J:151714
|
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
|
increased liver tumor incidence
|
J:153501
|
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified)
|
increased hepatic hemangioma incidence
|
J:178645
|
increased hepatocellular carcinoma incidence
|
J:178645
|
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified)
|
increased hepatic hemangioma incidence
|
J:178645
|
increased hepatocellular carcinoma incidence
|
J:178645
|
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch)
|
increased hepatocellular carcinoma incidence
|
J:244082
|
increased liver tumor incidence
|
J:244082
|
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
(involves: 129S1/Sv)
|
increased liver tumor incidence
|
J:218627
|
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
|
increased liver tumor incidence
|
J:231218
|
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:93269
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased hepatocellular carcinoma incidence
|
J:181296
|
Foxm1tm1Rhc/Foxm1tm1Rhc
(involves: 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:89472
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
increased hepatic hemangioma incidence
|
J:118179
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
increased hepatic hemangioma incidence
|
J:118179
|
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL)
|
increased liver tumor incidence
|
J:137456
|
G6pc1tm1.1Ics/G6pc1tm1.1Ics Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J)
|
increased liver adenoma incidence
|
J:195257
|
Gfertm1.1Crg/Gfertm1.1Crg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:227242
|
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
|
increased hepatic hemangioma incidence
|
J:146081
|
increased hepatocellular carcinoma incidence
|
J:146081
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:153656
|
increased liver adenoma incidence
|
J:153656
|
increased liver tumor incidence
|
J:153656
|
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ TgTn(sb-T2/Onc)68Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:147264
|
increased liver adenoma incidence
|
J:147264
|
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+ Trp53tm3Tyj/Trp53+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ TgTn(sb-T2/Onc)68Dla/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:147264
|
increased liver adenoma incidence
|
J:147264
|
Gtf2ird1Tg(Alb1-Myc)166.8Sst/0 Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1)
|
increased hepatocellular carcinoma incidence
|
J:4527
|
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
(involves: C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:34434,
J:101128
|
increased liver adenoma incidence
|
J:34434
|
increased liver tumor incidence
|
J:101128
|
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+ Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:101128
|
increased liver tumor incidence
|
J:101128
|
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+ Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1)
|
increased hepatocellular carcinoma incidence
|
J:34434
|
increased liver adenoma incidence
|
J:34434
|
H19tm1Tilg/H19+ Tg(CRP-TAg)60-3Urt/0
(involves: 129S/SvEv * BALB/c * C57BL/6 * SJL)
|
increased liver tumor incidence
|
J:90036
|
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa)
|
increased liver tumor incidence
|
J:296531
|
Hcif1C57BL/6J/Hcif1C57BR/cdJ Hcif2C57BL/6J/Hcif2C57BR/cdJ
(involves: C57BL/6J * C57BR/cdJ)
|
increased hepatoma incidence
|
J:33543
|
Hcif1C57BR/cdJ/?
(involves: C57BL/6J * C57BR/cdJ)
|
increased hepatoma incidence
|
J:33543
|
Hcs1C3H/He/?
(involves: A/J * C3H/He)
|
increased hepatoma incidence
|
J:3657
|
Hcs2C3H/He/?
(involves: A/J * C3H/He)
|
increased hepatoma incidence
|
J:3657
|
Hcs3A/J/?
(involves: A/J * C3H/He)
|
increased hepatoma incidence
|
J:3657
|
Hcs4C3H/He/Hcs4C57BL/6ByJ
(involves: C3H/He * C57BL/6JBy * M. spretus)
|
increased hepatoma incidence
|
J:20738
|
Hcs5C3H/He/?
(involves: C3H/He * C57BL/6ByJ * M. spretus)
|
increased hepatoma incidence
|
J:20738
|
Hcs6M. spretus/?
(involves: C3H/He * C57BL/6ByJ * M. spretus)
|
increased hepatoma incidence
|
J:20738
|
Hcs7C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased hepatoma incidence
|
J:31507
|
Hcs7C3H/HeJ/Hcs7C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased hepatoma incidence
|
J:91132
|
Hcs7C3H/HeJ/Hcs7C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased hepatoma incidence
|
J:91132
|
Hcs8CBA/J/Hcs8CBA/J
(involves: C57BL/6J * CBA/J)
|
increased hepatoma incidence
|
J:91132
|
Hcs9C57BR/cdJ/Hcs9C57BR/cdJ
(B6.BR-(D1Mit5-D1Mit17))
|
increased hepatoma incidence
|
J:91132
|
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:81448
|
Hif1atm3Rsjo/Hif1atm3Rsjo Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
increased hepatic hemangioma incidence
|
J:97652
|
Hip1tm4Tsr/Hip1+ Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:151974
|
increased liver tumor incidence
|
J:151974
|
Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
increased hepatic hemangioma incidence
|
J:97652
|
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:87066
|
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:87066
|
Ikbkgtm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased hepatocellular carcinoma incidence
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased hepatocellular carcinoma incidence
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:160521
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:118336
|
Il6tm1Kopf/Il6+ Ncoa5tm1Hxia/Ncoa5+
(involves: 129S2/SvPas * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:207622
|
Iqgap1tm1Aber/Iqgap1tm1Aber Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae)
|
increased hepatocellular carcinoma incidence
|
J:132670
|
Iqgap2tm1Vs/Iqgap2tm1Vs
(either: 129S4/SvJae-Iqgap2tm1Vs or B6.129S4-Iqgap2tm1Vs)
|
increased hepatocellular carcinoma incidence
|
J:132670
|
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae)
|
increased hepatocellular carcinoma incidence
|
J:205882
|
Krastm4Tyj/Kras+ Ptentm2Mak/Pten+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:254370
|
increased liver tumor incidence
|
J:254370
|
Krastm4Tyj/Kras+ Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased liver tumor incidence
|
J:254370
|
Krastm4Tyj/Kras+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased liver tumor incidence
|
J:254370
|
Krastm4Tyj/Krastm4Tyj Yap1tm1.1Dupa/Yap1tm1.1Dupa Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:162628
|
Krt18tm1Tmm/Krt18+
(involves: 129P2/OlaHsd)
|
increased liver tumor incidence
|
J:309021
|
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129P2/OlaHsd)
|
increased hepatocellular carcinoma incidence
|
J:309021
|
increased liver tumor incidence
|
J:309021
|
Lect2tm1Ymg/Lect2tm1Ymg Tg(Pklr-Myc)73Ak/0
(B6.Cg-Lect2tm1Ymg Tg(Pklr-Myc)73Ak)
|
increased hepatocellular carcinoma incidence
|
J:184496
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1)
|
increased hepatocellular carcinoma incidence
|
J:221030
|
Lzts1tm1Cro/Lzts1+
(involves: 129 * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:119989
|
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:119989
|
Mad1l1tm1.1Ktj/Mad1l1+
(involves: BALB/c * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:117337
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:160521
|
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:177386
|
Mcm4chaos3/Mcm4chaos3
(C3.B6-Mcm4chaos3)
|
increased hepatocellular carcinoma incidence
|
J:117494
|
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(AW0655)Wtsi
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
increased hepatocellular carcinoma incidence
|
J:177420
|
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
increased hepatocellular carcinoma incidence
|
J:177420
|
Mcm9Gt(XG743)Byg/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
increased hepatocellular carcinoma incidence
|
J:177420
|
Mdm2tm3.1Glo/Mdm2tm3.1Glo Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo)
|
increased liver adenocarcinoma incidence
|
J:164201
|
increased liver adenoma incidence
|
J:164201
|
Mdm2tm4.1Glo/Mdm2tm4.1Glo Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo)
|
increased liver adenocarcinoma incidence
|
J:164201
|
Mfsd1tm1a(KOMP)Wtsi/Mfsd1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased liver tumor incidence
|
J:280713
|
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:190066
|
Mir122tm1.1Kgh/Mir122+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:190067
|
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:190067
|
Mir122tm1.2Kgh/Mir122+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:190067
|
Mir122tm1.2Kgh/Mir122tm1.2Kgh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:190067
|
increased liver tumor incidence
|
J:190067
|
Mob1atm1.1Asuz/Mob1atm1.1Asuz Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased hepatocellular carcinoma incidence
|
J:228499
|
increased liver adenoma incidence
|
J:228499
|
Mob1atm1.2Asuz/Mob1atm1.2Asuz Mob1bGt(CC0690)Wtsi/Mob1b+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased liver tumor incidence
|
J:193981
|
Msh2tm1Htr/Msh2+
(involves: 129P2/OlaHsd)
|
increased liver tumor incidence
|
J:45433
|
Msh2tm1Rak/Msh2+
(involves: 129P2/OlaHsd)
|
increased liver adenoma incidence
|
J:64667
|
Mzf1tm1Ppp/Mzf1tm1Ppp
(involves: 129)
|
increased hepatocellular carcinoma incidence
|
J:70407
|
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased hepatocellular carcinoma incidence
|
J:195140
|
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6)
|
increased liver adenocarcinoma incidence
|
J:86563
|
increased liver adenoma incidence
|
J:86563
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:207622
|
Ncoa5tm1Hxia/Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia)
|
increased hepatocellular carcinoma incidence
|
J:207622
|
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased hepatocellular carcinoma incidence
|
J:210264
|
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased hepatocellular carcinoma incidence
|
J:210264
|
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6)
|
increased hepatoma incidence
|
J:18542
|
Nf1tm1Tyj/Nf1+ Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:217077
|
Nf2tm2Gth/Nf2tm2Gth Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:162628
|
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:97188
|
increased liver adenoma incidence
|
J:97188
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
|
increased hepatocellular carcinoma incidence
|
J:121075
|
increased liver adenoma incidence
|
J:121075
|
increased liver tumor incidence
|
J:121075
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:118204
|
increased liver adenoma incidence
|
J:118204
|
increased liver tumor incidence
|
J:118204
|
Nsmce2Gt(AA0032)Wtsi/Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased liver tumor incidence
|
J:227197
|
Nudt1tm1Tts/Nudt1tm1Tts
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
increased liver tumor incidence
|
J:71836
|
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac)
|
increased liver adenoma incidence
|
J:278655
|
Pex5tm1Pec/Pex5tm1Pec Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased liver tumor incidence
|
J:112503
|
Pinx1tm1.1Kplu/Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased liver tumor incidence
|
J:171997
|
Pinx1tm1.1Kplu/Pinx1+ Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:171997
|
increased liver tumor incidence
|
J:171997
|
Pinx1tm1.1Kplu/Pinx1+ Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:171997
|
increased liver tumor incidence
|
J:171997
|
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6)
|
increased liver tumor incidence
|
J:136425
|
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
increased liver adenoma incidence
|
J:162378
|
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:84677
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:84677
|
Prkar1atm1Gsm/Prkar1a+
(involves: 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:93393
|
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:73945
|
Ptentm1Hwu/Ptentm1Hwu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:218587
|
increased liver tumor incidence
|
J:218587
|
Ptentm1Hwu/Ptentm1Hwu Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * FVB/N)
|
increased hepatocellular carcinoma incidence
|
J:111718
|
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J)
|
increased liver adenoma incidence
|
J:53065
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:138099
|
increased liver adenoma incidence
|
J:138099
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)
|
increased hepatocellular carcinoma incidence
|
J:90905
|
increased liver adenoma incidence
|
J:90905
|
Ptentm2Mak/Ptentm2Mak Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:143082
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased liver adenoma incidence
|
J:172422
|
Rad50tm4.1Jpt/Rad50+
(involves: 129/Sv * C57BL/6)
|
increased hepatoblastoma incidence
|
J:209141
|
increased liver adenoma incidence
|
J:209141
|
increased liver tumor incidence
|
J:209141
|
Rad50tm4Jpt/Rad50+
(involves: 129/Sv * C57BL/6)
|
increased liver adenoma incidence
|
J:209141
|
increased liver tumor incidence
|
J:209141
|
Rag1tm1Mom/Rag1tm1Mom Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL)
|
increased hepatocellular carcinoma incidence
|
J:141515
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(Cd4-NPM/ALK)N1Ingh/0 Tg(TcraTcrb)1100Mjb/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
|
increased hepatocellular carcinoma incidence
|
J:235890
|
Ranbp2tm1Jvd/Ranbp2tm1.1Jvd
(involves: 129/Sv * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:137482
|
Ranbp2tm1Jvd/Ranbp2tm1Jvd
(involves: 129/Sv * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:137482
|
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl)
|
increased hepatocellular carcinoma incidence
|
J:202603
|
increased liver tumor incidence
|
J:202603
|
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ)
|
increased hepatocellular carcinoma incidence
|
J:231761
|
increased liver adenoma incidence
|
J:231761
|
increased liver tumor incidence
|
J:231761
|
Rassf1tm1Gpp/Rassf1tm1Gpp Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv * 129S1/SvImJ)
|
increased hepatoblastoma incidence
|
J:231761
|
increased hepatocellular carcinoma incidence
|
J:231761
|
increased liver adenoma incidence
|
J:231761
|
increased liver tumor incidence
|
J:231761
|
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
|
increased hepatocellular carcinoma incidence
|
J:168749
|
Rb1tm3Tyj/Rb1tm3Tyj Rbl1tm1Tyj/Rbl1tm1Tyj Rbl2tm2.1Tyj/Rbl2tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:177573
|
Rb1tm3Tyj/Rb1tm3Tyj Tg(tetO-MYC)36aBop/0 Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI)
|
increased hepatocellular carcinoma incidence
|
J:172430
|
increased liver tumor incidence
|
J:172430
|
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N)
|
increased hepatoma incidence
|
J:216929
|
Rcbtb2tm1.1Xyw/Rcbtb2+
(involves: C57BL/6 * CBA)
|
increased liver tumor incidence
|
J:282928
|
Rcbtb2tm1.1Xyw/Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA)
|
increased liver tumor incidence
|
J:282928
|
Rint1tm1Whl/Rint1+
(Not Specified)
|
increased hepatocellular carcinoma incidence
|
J:122805
|
Rr28tm1Tilg/Rr28+ Tg(CRP-TAg)60-3Urt/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
increased liver tumor incidence
|
J:138826
|
S100a4tm1Amba/S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
increased hepatocellular carcinoma incidence
|
J:89563
|
Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv)
|
increased hepatocellular carcinoma incidence
|
J:231761
|
increased liver adenoma incidence
|
J:231761
|
increased liver tumor incidence
|
J:231761
|
Sav1tm1.1Rjo/Sav1tm1.1Rjo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL)
|
increased hepatocellular carcinoma incidence
|
J:156531
|
Sav1tm1.1Rjo/Sav1tm1.1Rjo Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * CD-1 * SJL)
|
increased liver tumor incidence
|
J:156531
|
Sav1tm1.1Rjo/Sav1tm1.1Rjo Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)
|
increased liver tumor incidence
|
J:156531
|
Sav1tm1Dlim/Sav1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased hepatoma incidence
|
J:160325
|
increased liver tumor incidence
|
J:160325
|
Sav1tm1Dlim/Sav1tm1Dlim
(involves: 129S1/Sv * 129X1/SvJ)
|
increased liver tumor incidence
|
J:160325
|
Sav1tm2.1Dlim/Sav1tm2.1Dlim Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:238319
|
increased hepatoma incidence
|
J:160325
|
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss))
|
increased hepatocellular carcinoma incidence
|
J:177486
|
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:189320
|
Socs1tm1Jni/Socs1+
(Not Specified)
|
increased hepatoma incidence
|
J:91651
|
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:219360
|
increased liver tumor incidence
|
J:219360
|
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:132133
|
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac)
|
increased hepatocellular carcinoma incidence
|
J:166879
|
increased liver tumor incidence
|
J:166879
|
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased hepatoma incidence
|
J:119999
|
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas)
|
increased hepatocellular carcinoma incidence
|
J:184720
|
Stk3tm1.1Jav/Stk3+ Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:153945
|
Stk3tm1.1Jav/Stk3tm1.1Jav Stk4Gt(AJ0315)Wtsi/Stk4+
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:153945
|
Stk3tm1.1Jav/Stk3tm1Jav Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:153945
|
Stk3tm1.1Rjo/Stk3tm1.1Rjo Stk4tm1.1Rjo/Stk4tm1.1Rjo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL)
|
increased hepatocellular carcinoma incidence
|
J:156531
|
increased liver tumor incidence
|
J:156531
|
Stk3tm1.1Yy/Stk3tm1Yy Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA)
|
increased liver tumor incidence
|
J:156541
|
Stk3tm1.1Yy/Stk3tm1Yy Stk4tm1.1Yy/Stk4tm1.1Yy Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:156541
|
increased liver tumor incidence
|
J:156541
|
Stk3tm1Jav/Stk3tm1Jav Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:153945
|
Stk3tm1Jav/Stk3tm1Jav Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:153945
|
Stk3tm1Jav/Stk3tm1Jav Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:238319
|
Stk11tm1Mmt/Stk11+
(involves: 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:76202
|
Stk11tm1Mmt/Stk11+ Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * 129X1/SvJ)
|
increased hepatocellular carcinoma incidence
|
J:107275
|
increased liver tumor incidence
|
J:107275
|
Stk11tm1Tpm/Stk11+
(Not Specified)
|
increased hepatocellular carcinoma incidence
|
J:79074
|
increased liver adenoma incidence
|
J:79074
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak)
|
increased hepatocellular carcinoma incidence
|
J:184496
|
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified)
|
increased liver adenoma incidence
|
J:89878
|
Tg(Alb1-Myc)#Sst/0
(involves: C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:34434
|
increased liver adenoma incidence
|
J:34434
|
Tg(Alb1-Myc)#Sst/0 Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1)
|
increased hepatocellular carcinoma incidence
|
J:34434
|
increased liver adenoma incidence
|
J:34434
|
Tg(Alb1-Myc)#Sst/0 Tg(MtTGFA)Lmb/0
(involves: C57BL/6 * CBA * CD-1)
|
increased hepatocellular carcinoma incidence
|
J:176432
|
Tg(Alb1HBV)43Bri/0
(involves: C57BL/6J)
|
increased liver tumor incidence
|
J:86165
|
Tg(Alb1HBV)44Bri/0
(involves: C57BL/6J * SJL/J)
|
increased hepatocellular carcinoma incidence
|
J:86165
|
increased liver adenoma incidence
|
J:86165
|
increased liver tumor incidence
|
J:86165
|
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J)
|
increased hepatocellular carcinoma incidence
|
J:223921
|
increased liver adenoma incidence
|
J:223921
|
increased liver tumor incidence
|
J:223921
|
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J)
|
increased hepatocellular carcinoma incidence
|
J:65354,
J:101128
|
increased liver adenoma incidence
|
J:65354
|
increased liver tumor incidence
|
J:65354,
J:101128
|
Tg(Alb-HBx)A112Tfts/0
(involves: C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:104728
|
Tg(Alb-HRAS*G12V)28Yu/0
(involves: C57BL/6J * CBA/J)
|
increased hepatocellular carcinoma incidence
|
J:107083,
J:238319
|
increased liver adenoma incidence
|
J:107083,
J:238319
|
increased liver tumor incidence
|
J:107083,
J:238319
|
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:96979,
J:211984
|
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA)
|
increased hepatocellular carcinoma incidence
|
J:242582
|
Tg(Alb-TAg)1Gjh/0
(C3.Cg-Tg(Alb-TAg)1Gjh)
|
increased hepatocellular carcinoma incidence
|
J:105110
|
Tg(Alb-TAg)#Arnd/0
(C3Fe.Cg-Tg(Alb-TAg)#Arnd)
|
increased hepatocellular carcinoma incidence
|
J:171880
|
Tg(Amy1TAg)354Knw/0
(C57BL/6J-Tg(Amy1TAg)354Knw)
|
increased hepatoma incidence
|
J:90326
|
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
|
increased liver tumor incidence
|
J:158388
|
Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA)
|
increased liver tumor incidence
|
J:181238
|
Tg(Cd4-NPM/ALK)N1Ingh/0 Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster)
|
increased hepatocellular carcinoma incidence
|
J:235890
|
Tg(Cebpb-tTA)5Bjd/0 Tg(tetO-MYC,-OVAL)#Gtgm/0
(B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm)
|
increased hepatocellular carcinoma incidence
|
J:186226
|
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
increased liver adenoma incidence
|
J:94953
|
increased liver tumor incidence
|
J:94953
|
Tg(Fabp1-Ccnd1)2Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)2Rdb)
|
increased liver adenoma incidence
|
J:70394
|
Tg(Fabp1-Ccnd1)4Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)4Rdb/J)
|
increased hepatocellular carcinoma incidence
|
J:70394
|
increased liver adenoma incidence
|
J:70394
|
Tg(HBV-HCV)21Kko/0
(C57BL/6N-Tg(HBV-HCV)21Kko)
|
increased hepatocellular carcinoma incidence
|
J:52686
|
increased liver adenoma incidence
|
J:52686
|
Tg(HBV-HCV)49Kko/0
(C57BL/6N-Tg(HBV-HCV)49Kko)
|
increased hepatocellular carcinoma incidence
|
J:52686
|
increased liver adenoma incidence
|
J:52686
|
Tg(HBV-HCV)Kko/0
(C57BL/6N-Tg(HBV-HCV)Kko)
|
increased hepatocellular carcinoma incidence
|
J:52686
|
increased liver adenoma incidence
|
J:52686
|
Tg(HBVX*,-Myc)#Skp/0
(Not Specified)
|
increased hepatocellular carcinoma incidence
|
J:81098
|
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified)
|
increased hepatocellular carcinoma incidence
|
J:81098
|
Tg(HBx)3Yu/0
(involves: C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:56196
|
Tg(Hnf1a-RB1*)XMiu/?
(Not Specified)
|
increased liver adenoma incidence
|
J:180294
|
Tg(IRS1)1Mhep/0 Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * FVB * ICR)
|
increased hepatocellular carcinoma incidence
|
J:227278
|
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA)
|
increased hepatoma incidence
|
J:144382
|
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA)
|
increased hepatoma incidence
|
J:144382
|
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CD-1)
|
increased liver tumor incidence
|
J:2578
|
Tg(MtTGFA)42Lmb/0
(involves: CD-1 * FVB/N)
|
increased liver tumor incidence
|
J:2578
|
Tg(MtTGFA)42Lmb/Tg(MtTGFA)42Lmb
(involves: CD-1)
|
increased hepatocellular carcinoma incidence
|
J:28452
|
Tg(Mup3-Plau)350-2Eps/0
(involves: C57BL/6)
|
increased liver tumor incidence
|
J:66132
|
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps)
|
increased hepatocellular carcinoma incidence
|
J:233146
|
increased liver adenoma incidence
|
J:233146
|
increased liver tumor incidence
|
J:233146
|
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
increased hepatocellular carcinoma incidence
|
J:187236,
J:77160
|
increased liver tumor incidence
|
J:77160
|
Tg(Pklr-HRAS*G12V)23Ak/0
(involves: C57BL/6 * DBA/2)
|
increased hepatocellular carcinoma incidence
|
J:44803
|
increased hepatoma incidence
|
J:44803
|
Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:185488
|
increased hepatoma incidence
|
J:185488
|
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak)
|
increased hepatocellular carcinoma incidence
|
J:184496
|
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA)
|
increased hepatocellular carcinoma incidence
|
J:185488
|
increased hepatoma incidence
|
J:185488
|
Tg(SERPINA1-TAg)1812Jtsb/0
(involves: C3H * C57BL/6 * ICR)
|
increased hepatocellular carcinoma incidence
|
J:101633
|
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2)
|
increased hepatocellular carcinoma incidence
|
J:101541
|
Tg(SERPINC1-SV40)A1Pbr/Tg(SERPINC1-SV40)A1Pbr
(involves: C57BL/6 * DBA/2)
|
increased hepatocellular carcinoma incidence
|
J:101541
|
X/Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2)
|
increased hepatocellular carcinoma incidence
|
J:84204,
J:101541
|
increased liver adenoma incidence
|
J:84204
|
Tg(Tal1-cre/ERT)1Jrg/0 Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6)
|
increased liver tumor incidence
|
J:231316
|
Tg(tetO-MET)23Rwng/0 Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI)
|
increased hepatocellular carcinoma incidence
|
J:69731
|
Tg(tetO-MYC)36aBop/0 Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI)
|
increased hepatoblastoma incidence
|
J:93899
|
increased hepatocellular carcinoma incidence
|
J:172430,
J:186226,
J:190067,
J:93899
|
increased liver tumor incidence
|
J:172430,
J:93899
|
Thbs1tm1Hyn/Thbs1tm1Hyn Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased liver adenocarcinoma incidence
|
J:72391
|
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:140639
|
increased hepatoma incidence
|
J:140639
|
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:140639
|
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J)
|
increased hepatocellular carcinoma incidence
|
J:184948
|
Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL)
|
increased hepatocellular carcinoma incidence
|
J:130210
|
increased liver adenoma incidence
|
J:130210
|
increased liver tumor incidence
|
J:130210
|
Trim62tm1Akil/Trim62+
(involves: 129S/SvEv * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:204336
|
increased liver adenocarcinoma incidence
|
J:204336
|
Trim62tm1Akil/Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6)
|
increased liver adenocarcinoma incidence
|
J:204336
|
Trp53tm1.1Xlu/Trp53tm1.1Xlu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * FVB/N)
|
increased liver tumor incidence
|
J:166152
|
Trp53tm1Tyj/Trp53+ Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased hepatocellular carcinoma incidence
|
J:98958
|
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae)
|
increased hepatocellular carcinoma incidence
|
J:95316
|
Tsc1tm1.1Djk/Tsc1+
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J))
|
increased hepatic hemangioma incidence
|
J:75243
|
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C57BL/6JOlaHsd)
|
increased hepatic hemangioma incidence
|
J:99796
|
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * Balb/cOlaHsd * C57BL/6JOlaHsd)
|
increased hepatic hemangioma incidence
|
J:99796
|
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C3H/HeNHsd * C57BL/6JOlaHsd)
|
increased hepatic hemangioma incidence
|
J:99796
|
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J)
|
increased hepatic hemangioma incidence
|
J:70463
|
Tsc2tm1Djk/Tsc2+
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J))
|
increased hepatic hemangioma incidence
|
J:57631
|
Tsc2tm1Tno/Tsc2+
(involves: 129S4/SvJae * C57BL/6J)
|
increased hepatic hemangioma incidence
|
J:52464
|
Tspan33tm1Stsa/Tspan33tm1Stsa
(involves: 129S1/Sv * 129X1/SvJ)
|
increased liver tumor incidence
|
J:143158
|
TxnipHyplip1/Txnip+
(involves: CAST/Ei * HcB19/Dem)
|
increased hepatocellular carcinoma incidence
|
J:112292
|
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1)
|
increased hepatocellular carcinoma incidence
|
J:112292
|
TxnipHyplip1/TxnipHyplip1
(involves: CAST/Ei * HcB19/Dem)
|
increased hepatocellular carcinoma incidence
|
J:112292
|
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
|
increased hepatocellular carcinoma incidence
|
J:157049
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
increased hepatocellular carcinoma incidence
|
J:164423
|
Usp24Gt(XB614)Byg/Usp24+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased liver tumor incidence
|
J:303991
|
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased hepatoma incidence
|
J:193965
|
Vhltm1.1Jae/Vhl+
(involves: 129S4/SvJae * BALB/c)
|
increased hepatic hemangioma incidence
|
J:67505
|
Vhltm1.1Lss/Vhl+
(involves: BALB/c)
|
increased hepatic hemangioma incidence
|
J:85513
|
Vhltm1Lss/Vhltm1.1Lss
(involves: 129X1/SvJ * C57BL/6)
|
increased hepatic hemangioma incidence
|
J:85513
|
Vhltm1Lss/Vhltm1.1Lss Tg(ACTB-cre)1Tes/0
(involves: 129X1/SvJ * C3H * C57BL/6)
|
increased hepatic hemangioma incidence
|
J:85513
|
Wwc1tm1Arsc/Wwc1tm1Arsc Wwc2tm1.1Arte/Wwc2tm1.1Arte Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * C57BL/6J * DBA)
|
increased liver tumor incidence
|
J:305034
|
Xpatm1Tnka/Xpatm1Tnka
(C3.Cg-Xpatm1Tnka)
|
increased liver adenoma incidence
|
J:76206
|
increased liver tumor incidence
|
J:76206
|